Novartis AG

Overview

Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz. Novartis conducts research in various disease areas through The Novartis Institutes for BioMedical Research (NIBR). The company operates through a network of subsidiaries and offices across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Novartis is headquartered in Basel, Switzerland.
Key Stats
Address
Lichtstrasse 35, BASEL, Switzerland
Headquarters

Switzerland

Contact

41 61 3241111

No of Employees

110,000

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

NOVN [SWF]

Revenue (2020)

$49,898 m

2.6% (2020 vs 2019)
Net Income (2020)

$8,072 m

-31.2% (2020 vs 2019)
Net Profit Margin

16 %

-33% (2020 vs 2019)
Market Cap *

$230,776 m

EPS *

$3.5

  *Note: Ratios based on the share price as of 11-June-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Novartis AGJohnson & JohnsonF. Hoffmann-La Roche LtdMerck & Co Inc
Key Information
Headquarters Switzerland United States of America Switzerland United States of America
Headquarter City BASEL NEW BRUNSWICK BASEL KENILWORTH
Headquarter State/Province - New Jersey - New Jersey
No. of Employees 110,000 134,500 101,465 74,000
Entity Type Public Public Public Public
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age
Thomas N. Kendris Chief Legal Officer - Interim Senior Management 2021 -
Simon Moroney Director Non Executive Board 2020 63
Non Dignissim Eros Proin vel Convallis 2015 XX
Non Dignissim Eros Proin vel Convallis 2015 XX
Non Dignissim Eros Proin vel Convallis 2015 XX
Non Dignissim Eros Proin vel Convallis 2015 XX

History

Year Event Description
2021 Regulatory Approval In February, the company secured the Therapeutic Goods Administration approval to manufacture and supply its…
2021 Contracts/Agreements In March, the company along with Puma Biotechnology, Celcuity, and the MD Anderson Cancer Center…
2021 Contracts/Agreements In April, the company and Artios Pharma entered into a global research collaboration to validate…
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Alcon Cusi SA

Address

C.Camil Fabra, 58, El Masnou
Spain

Telephone

34 901 120303

Website

www.alcon.es
Lek dd

Address

Verovskova 57, Ljubljana
Slovenia

Telephone

386 15 802111

Website

www.lek.si
1 A Pharma GmbH

Address

Keltenring 1 + 3, Oberhaching
Germany

Telephone

49 89 61388250

Website

www.1apharma.de
Novartis Healthcare Philippines Inc

Address

Asian Reinsurance Bldg, Salcedo & Gamboa Streets, Legaspi Village, Makati
Philippines

Telephone

63 2 3687777

Website

www.novartis.com.ph
Novartis Animal Health GmbH

Address

Biochemiestrasse 10, Kundl
Austria

Telephone

43 5338 2002865

China Novartis Institutes for BioMedical Research Co Ltd

Address

No. 4218, Jinke Road, Zhangjiang Hi-tech Park, Pudong
China

Telephone

86 21 61606000

Website

www.nibr.com
Speedel Holding AG

Address

Hirschgaesslein 11, Basel
Switzerland

Telephone

41 61 2064000

Website

www.speedel.com
Novartis Chile SA

Address

9th Floor, Mistral Building, Rosario Norte 615, Las Condes, Santiago
Chile

Telephone

56 2 23500200

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
01 Jun 2021 Novartis Plans to Acquire Cellerys Acquisition Novartis AG Cellerys AG
01 Jun 2021 Novartis Enters into Agreement with Cellerys Partnership Cellerys AG; Novartis AG
01 Jun 2021 Novartis Plans to Acquire Cellerys Acquisition Novartis AG Cellerys AG
28 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
23 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
15 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

1.7K

Active Jobs

881

Posted

1K

Closed

Job Trends

Latest Jobs

Job title Company Country
Director TPRM Processes Novartis AG Switzerland
Director Learning Innovation (80-100%)* Novartis AG Switzerland
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar